Use of anti-CMV immunoglobulins in lung transplant recipients: The French experience.

This study describes an unusual indication of CMVIG use as a last resort treatment in complex situations, based on clinical needs. CMVIG could be useful to change the course of CMV infection with minimal adverse effects or comorbidity.